e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Connective tissue disease and interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rituximab in severe, treatment-refractory interstitial lung disease
R. Abdullah, D. Ming, G. Keir, T. Maher, A. Wells, E. Renzoni (London, United Kingdom)
Source:
Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Session:
Connective tissue disease and interstitial lung disease
Session type:
Poster Discussion
Number:
5127
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Abdullah, D. Ming, G. Keir, T. Maher, A. Wells, E. Renzoni (London, United Kingdom). Rituximab in severe, treatment-refractory interstitial lung disease. Eur Respir J 2013; 42: Suppl. 57, 5127
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012
Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018
Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019
Interstitial lung disease
Source: ERS Course 2015
Year: 2015
Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014
Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019
Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept